Investigation Report on China Edaravone Market, 2010-2019

Publisher Name :
Date: 11-Jun-2015
No. of pages: 30

Description

Cerebrovascular disease is one of the three principal diseases that can cause people to death. Acute cerebral infarction which occupies 70% of cerebrovascular disease has a disability rate of 50%70% and a recurrence rate of 40%. And one thing to be noted is that the more relapses people have, the higher the mortality and disability.

Acute cerebral infarction, one of the serious threats to old people's health, features sudden onset, complex pathogenesis and "three high and one low": high morbidity, high mortality, high fatality and low cure rate.

Edaravone injection, a lifesaving drug for the treatment of acute cerebral infarction, is the only free radical scavenger in the world with a clear mechanism and target of acute cerebral infarction. Ever since its debut in Japan in 2002, its sales in the first 13 months has surpassed JPY 40 billion.

Simcere is China's first and world's second manufacturer of Edaravone injection. Its new product "Bi Cun" is priced at 1/33 of the price of similar products in Japan. In 2007, "Bi Cun" spread over China with a market share of 74.62%. According to CRI's statistics, Edaravone develops fast after entering China, annual sales value rising from less than CNY 50 million in 2005 to CNY 629 million in 2014 and CAGR reaching up to 34.3% during the period of 20052015. Currently, local manufacturers of Edaravone are as follows: Simcere, Jilin Boda Pharmaceutical Co., Ltd, Jilin Province Huinan Changlong Biopharmacy Co., Ltd and Kunming Jida Pharmaceutical Co., Ltd, among which Simcere has the largest market share of 39% with sales value reaching up to CNY 246 million in 2014.

With the ageing population, the incidence of acute cerebral infarction in China will keep increasing, thus promoting the growth of Edaravone market.

Readers can get at least the following information from this report:


  • market size of Edaravone in China

  • market share of manufacturers of Edaravone in China

  • price of Edaravone in Chinese market

  • major manufacturers of Edaravone in Chinese market

  • market outlook of Edaravone in China


The author suggests the following groups of people purchase this report:


  • manufacturers of cerebrovascular drugs

  • investors/ research institutions interested in Chinese medicine market

  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Investigation Report on China Edaravone Market, 2010-2019

Table of Contents

1 Related Concepts of Edaravone
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Edaravone in China
2.1 Patent and Approval Status of Edaravone in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Edaravone in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Edaravone in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Edaravone in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Edaravone in Chinese Hospitals in 2014
6.1 Kunming Jida Pharmaceutical Co., Ltd
6.2 Nanjing Simcere Dongyuan Pharmaceutical Co.,Ltd.
6.3 Jilin Boda Pharmaceutical Co., Ltd (Trade Name: Yi Da Sheng)
6.4 Jilin Province Huinan Changlong Biopharmacy Co., Ltd (Trade Name: Qing Tong)
6.5 China National Medicines Guorui Pharmaceutical Co., Ltd
6.6 Science & Technology General Company Hebei Medical University (Trade Name: Kai Da Fu Xin)
6.7 Fujian Tianquan Pharmaceutical Co., Ltd
6.8 Shaanxi Jianmin Pharmaceutical Co., Ltd (Trade Name: Bai Yi Da)

7 Major Manufacturers of Edaravone in Chinese Market, 2010-2014
7.1 Jilin Boda Pharmaceutical Co., Ltd
7.2 Jilin Province Huinan Changlong Biopharmacy Co., Ltd
7.3 Nanjing Simcere Dongyuan Pharmaceutical Co.,Ltd.
7.4 Kunming Jida Pharmaceutical Co., Ltd
7.5 China National Medicines Guorui Pharmaceutical Co., Ltd

8 Market Outlook of Edaravone in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Charts

Chart Approval Information of Edaravone in China
Chart Sales Status of Edaravone in China, 2010-2014
Chart Sales Value of Edaravone in China, 2010-2014
Chart Sales Value of Edaravone in Some Regions in China, 2010-2014
Chart Sales Volume of Edaravone in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Edaravone for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Edaravone Made by Simcere in China, 2010-2014
Chart Sales Value and Market Share of Edaravone Made by Jilin Boda in China, 2010-2014
Chart Sales Value and Market Share of Edaravone Made by Kunming Jida in China, 2010-2014
Chart Sales Value and Market Share of Edaravone Made by Huinan Changlong in China, 2010-2014
Chart Sales Value and Market Share of Edaravone Made by Guorui in China, 2010-2014
Chart Sales Value and Market Share of Edaravone Injection in China, 2010-2014
Chart Price of Edaravone Made by Kunming Jida Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Edaravone Made by Simcere in Some Chinese Cities in 2014
Chart Price of Edaravone Made by Jilin Boda Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Edaravone Made by Jilin Province Huinan Changlong Biopharmacy Co., Ltd in Some Chinese Cities in 2014
Chart Price of Edaravone Made by China National Medicines Guorui Pharmaceutical Co., Ltd in Some Chinese Cities in 2014

  • Global Narcolepsy Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80
    According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......
  • Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Epilepsy Drugs market: According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years. Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......
  • Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......
  • Migraine Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Neuromyelitis Optica Drug market: According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Narcolepsy Drug market: According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years. Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles. This......
  • Global Edaravone Market Research Report 2023
    Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Unichem Laboratories Ltd - UCB India Ltd - Piram......
  • Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Ethoxyquin market: According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years. Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......
  • Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Antipsychotic Drugs market: According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs